These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9357866)

  • 1. rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation.
    Uchiba M; Okajima K; Murakami K; Johno M; Mohri M; Okabe H; Takatsuki K
    Am J Physiol; 1997 Oct; 273(4):L889-94. PubMed ID: 9357866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation.
    Uchiba M; Okajima K; Murakami K; Johno M; Okabe H; Takatsuki K
    Am J Physiol; 1996 Sep; 271(3 Pt 1):L470-5. PubMed ID: 8843797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection by recombinant thrombomodulin.
    Taoka Y; Okajima K; Uchiba M; Johno M
    Thromb Haemost; 2000 Mar; 83(3):462-8. PubMed ID: 10744154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.
    Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K
    Blood; 1996 Jan; 87(2):642-7. PubMed ID: 8555486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.
    Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K
    Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of human urinary thrombomodulin on endotoxin-induced intravascular coagulation and pulmonary vascular injury in rats.
    Uchiba M; Okajima K; Murakami K; Johno M; Okabe H; Takatsuki K
    Am J Hematol; 1997 Feb; 54(2):118-23. PubMed ID: 9034285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats.
    Gonda Y; Hirata S; Saitoh K; Aoki Y; Mohri M; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T
    Thromb Res; 1993 Aug; 71(4):325-35. PubMed ID: 8236161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human soluble thrombomodulin on experimental glomerulonephritis.
    Ikeguchi H; Maruyama S; Morita Y; Fujita Y; Kato T; Natori Y; Akatsu H; Campbell W; Okada N; Okada H; Yuzawa Y; Matsuo S
    Kidney Int; 2002 Feb; 61(2):490-501. PubMed ID: 11849389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human soluble thrombomodulin delivers bounded thrombin to antithrombin III: thrombomodulin associates with free thrombin and is recycled to activate protein c.
    Aritomi M; Watanabe N; Ohishi R; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
    Thromb Haemost; 1993 Sep; 70(3):418-22. PubMed ID: 8259541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats.
    Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K
    Thromb Res; 1995 Apr; 78(2):117-25. PubMed ID: 7482429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma.
    Ohishi R; Watanabe N; Aritomi M; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
    Thromb Haemost; 1993 Sep; 70(3):423-6. PubMed ID: 8259542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma.
    Mohri M; Suzuki M; Sugimoto E; Sata M; Yamamoto S; Maruyama I
    Thromb Haemost; 1998 Dec; 80(6):925-9. PubMed ID: 9869162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic effects of recombinant human soluble thrombomodulin (rhs-TM) on arteriovenous shunt thrombosis in rats.
    Aoki Y; Takei R; Mohri M; Gonda Y; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T; Maruyama I
    Am J Hematol; 1994 Nov; 47(3):162-6. PubMed ID: 7942778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of pulmonary thromboembolism by neutrophil elastase in collagen-induced arthritis mice and effect of recombinant human soluble thrombomodulin.
    Matsuoka T; Jin E; Tachihara A; Ghazizadeh M; Nakajima A; Yoshino S; Katayama Y; Kawanami O
    Pathobiology; 2008; 75(5):295-305. PubMed ID: 18931532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
    Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombomodulin].
    Ohmori Y; Takahashi Y
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):283-9. PubMed ID: 11215378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats.
    Hasegawa N; Kandra TG; Husari AW; Veiss S; Hart WT; Hedgpeth J; Wydro R; Raffin TA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1831-7. PubMed ID: 8665042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevention of lipopolysaccharide-induced pulmonary vascular injury by pretreatment with cepharanthine in rats.
    Murakami K; Okajima K; Uchiba M
    Am J Respir Crit Care Med; 2000 Jan; 161(1):57-63. PubMed ID: 10619798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
    Uchiba M; Okajima K; Murakami K; Okabe H; Okamoto S; Okada Y
    Thromb Haemost; 1997 Oct; 78(4):1209-14. PubMed ID: 9364986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation.
    Enkhbaatar P; Okajima K; Murakami K; Uchiba M; Okabe H; Okabe K; Yamaguchi Y
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1752-9. PubMed ID: 11069808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.